您的位置: 首页 > 2018年5月 第49卷 第3期 > 文字全文
2023年7月 第38卷 第7期11
目录

帕金森病与血管性帕金森综合征患者磁敏感加权成像的应用价值探析

Application value of SWI in patients with Parkinson's disease and vascular Parkinson's syndrome

来源期刊: 广州医药 | 109-112 发布时间:2021-12-01 收稿时间:2025/11/13 17:22:53 阅读量:28
作者:
关键词:
帕金森病血管性帕金森综合征磁敏感加权成像
Parkinson's diseaseVascularized Parkinson's syndromeMagnetic susceptibility weighted imaging
DOI:
10.3969/j.issn.1000-8535.2018.03.032
收稿时间:
2018-02-04 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探究磁敏感加权成像(SWI)对帕金森病(PD)与血管性帕金森综合征(VPS)的鉴别诊断价值。方法 回顾性分析我院2013年1月—2016年12月收治的30例PD患者(PD组)和30例VPS患者(VPS)组SWI分析结果,比较两组患者的脑椎体外系各核团的相位值差异,同时将两组患者的测量值与来我院行常规体检的正常者作为对照组进行测量比较。结果 PD组患者的黑质致密带(SNc)、苍白球(GP)、壳核(PUT)相位值较VPS组、对照组更低,组间数据对比有差异(P<0.05);而对照组的SNc、GP、PUT的相位值与VPS组相比无差异(P>0.05);三组对象的红核(RN)、尾状核(CN)测量值无差异(P>0.05);采用Hoehn&Yahr对PD患者和VPS进行分级后发现,各级PD患者SNc相位值之间差异均有统计学意义(P<0.05),VPS组Ⅰ~Ⅱ级、III级与IV级患者相比,SNc、PUT、尾状核(CN)有统计学差异(P<0.05),而RN相位值无差异(P>0.05)。结论 采用磁敏感加权成像对PD患者和VPS患者的椎体外系各核团的相位值进行测量,能对两者的鉴别起到较大的参考价值。
Objective To explore the value of magnetic susceptibility weighted imaging (SWI) in the differential diagnosis of Parkinson's disease (PD) and vascularized Parkinson's syndrome (VPS). Methods The results of SWI analysis of 30 patients with PD (PD) and 30 patients with VPS (VPS) from January 2013 to December 2016 were retrospectively analyzed. The results were compared between the two groups. Of the phase value of the difference between the two groups of patients with the measured values and routine examination of our hospital as a control group for comparison. Results The phase values of the substantia nigra (SNc), globus pallidus (GP) and crustal nucleus (PUT) were significantly lower in the PD group than in the VPS group and the control group (P <0.05).There was no significant difference in the GP and PUT values between the control group and the VPS group (P> 0.05).There was no significant difference in the red nuclei (RN) between the three groups (P> 0.05).There was significant difference in SNc phase values between PD patients at all levels (P <0.05). Compared with patients with grade IV, grade I and II were higher than those of patients with grade IV (P <0.05), and the difference was statistically significant (P <0.05) between PD patients and VPS. (P <0.05), but there was no significant difference (P> 0.05) between the PUT and the caudate nucleus (CN). Conclusion The phase value of the nucleus of the vertebral body in PD patients and VPS patients was measured by magnetic susceptibility weighted imaging, which could be used as a reference for the identification of the two.
1、 NOEBAUER-HUHMANN I M,PINKER K,BARTH M,et al.Contrast-enhanced, high-resolution, susceptibility-weighted imaging of the brain:dose-dependent optimization at 3 tesla and 1.5 tesla in healthy volunteers[J]. Invest Radiol,2012, 41(3):249-255. NOEBAUER-HUHMANN I M,PINKER K,BARTH M,et al.Contrast-enhanced, high-resolution, susceptibility-weighted imaging of the brain:dose-dependent optimization at 3 tesla and 1.5 tesla in healthy volunteers[J]. Invest Radiol,2012, 41(3):249-255.
2、 王铁铮,林祥涛,赵斌.磁敏感加权成像对帕金森病脑核团的显示及其铁沉积差异测定[J]. 医学影像学杂志,2013,9:1345-1349. 王铁铮,林祥涛,赵斌.磁敏感加权成像对帕金森病脑核团的显示及其铁沉积差异测定[J]. 医学影像学杂志,2013,9:1345-1349.
3、 SITBURANA O,ONDO WG.Brain magnetic resonance imaging(MRI) in parkinsonian disorders[J]. Parkinsonism Relat Disord,2013,15(3):165-174. SITBURANA O,ONDO WG.Brain magnetic resonance imaging(MRI) in parkinsonian disorders[J]. Parkinsonism Relat Disord,2013,15(3):165-174.
4、 SEHGAL V,DELPROPOSTO Z,HAACKE E M,et al.Clinical applications of neuroimaging with susceptibility-weighted imaging[J]. J Magn Reson Imaging,2014,22(4):439-450. SEHGAL V,DELPROPOSTO Z,HAACKE E M,et al.Clinical applications of neuroimaging with susceptibility-weighted imaging[J]. J Magn Reson Imaging,2014,22(4):439-450.
5、 ZHANG J,ZHANG Y,WANG J,et al.Characterizing iron deposition in Parkinson's disease using suceptibility-weighted imaging:an in vivo MR study[J]. Brain Res, 2014,1330: 124-130. ZHANG J,ZHANG Y,WANG J,et al.Characterizing iron deposition in Parkinson's disease using suceptibility-weighted imaging:an in vivo MR study[J]. Brain Res, 2014,1330: 124-130.
6、 何晓鹏,欧光乾,韩福刚.中枢神经细胞瘤的CT及MR诊断与鉴别诊断[J]. 重庆医学,2013,40(13):1275-1277. 何晓鹏,欧光乾,韩福刚.中枢神经细胞瘤的CT及MR诊断与鉴别诊断[J]. 重庆医学,2013,40(13):1275-1277.
7、 董玉茹,王宏,马毅,等.水成像在视神经磁共振扫描中的应用[J]. 中国CT和MRI杂志,2015,13(2):15-17. 董玉茹,王宏,马毅,等.水成像在视神经磁共振扫描中的应用[J]. 中国CT和MRI杂志,2015,13(2):15-17.
8、 BOHLHALTER S,ABELA E,HALLETT M.Functional MRI of impaired finger dexterity in Parkinson's disease[J]. Exp-Neurol,2011,227(1):24-25. BOHLHALTER S,ABELA E,HALLETT M.Functional MRI of impaired finger dexterity in Parkinson's disease[J]. Exp-Neurol,2011,227(1):24-25.
9、 MANOVA E S, HABIB C A, BOIKOV A S, et al. Characterizing the mesencephalon using susceptibility-weighted imaging[J]. Am J Neuroradiol,2015,30(3):569-574. MANOVA E S, HABIB C A, BOIKOV A S, et al. Characterizing the mesencephalon using susceptibility-weighted imaging[J]. Am J Neuroradiol,2015,30(3):569-574.
10、 王慈,范国光,徐克,等.磁敏感加权成像定量测量在鉴别诊断帕金森病和血管性帕金森综合征中的应用[J]. 中国医学影像学杂志,2012,3(1):161-165. 王慈,范国光,徐克,等.磁敏感加权成像定量测量在鉴别诊断帕金森病和血管性帕金森综合征中的应用[J]. 中国医学影像学杂志,2012,3(1):161-165.
11、 蒋雨平,王坚,丁正同.原发性帕金森病的诊断标准[J]. 中国临床神经科学,2006,14(1):40. 蒋雨平,王坚,丁正同.原发性帕金森病的诊断标准[J]. 中国临床神经科学,2006,14(1):40.
12、 BENARROCH E E.Brain iron homeostasis and neurodegenerative disease[J]. Neurol,2013,72(16):1436-1440. BENARROCH E E.Brain iron homeostasis and neurodegenerative disease[J]. Neurol,2013,72(16):1436-1440.
13、 ZHANG J, ZHANG Y, WANG J, et al. Characterizing iron deposition in parkinson's disease using suceptibility-weighted imaging:an in vivo MR study[J]. Brain Res,2015,3(14):124-130. ZHANG J, ZHANG Y, WANG J, et al. Characterizing iron deposition in parkinson's disease using suceptibility-weighted imaging:an in vivo MR study[J]. Brain Res,2015,3(14):124-130.
14、 储佺兵,胡中华,解渊,等.磁敏感加权成像在帕金森病及血管性帕金森综合征诊断、鉴别诊断中的临床研究[J]. 中国CT和MRI杂志, 2015,13(8):8-13. 储佺兵,胡中华,解渊,等.磁敏感加权成像在帕金森病及血管性帕金森综合征诊断、鉴别诊断中的临床研究[J]. 中国CT和MRI杂志, 2015,13(8):8-13.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录